RPM International
RPM NYSE Specialty Chemicals Financials FY2017βFY2026
RPM International's revenue rose 6.7% to $7.9 billion in fiscal 2026. Its net margin was 8.4%, down from 9.3% a year earlier. Free cash flow was $675 million, up 25.4%. It paid out $349 million in dividends and buybacks, 52% of free cash flow. The diluted share count fell 0.5%.
What RPM International does
No business description yet.
- Legal name
- RPM International Inc.
- Fiscal year ends
- May 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-312142
0000110621
Revenue and margins
RPM International had $7.9B of revenue in fiscal 2026, up 6.7% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 16.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $675M in fiscal 2026, 8.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
RPM International returned $349M to shareholders in fiscal 2026, 52% of free cash flow. The diluted share count fell 0.5%.
Value RPM International yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.2B and divides by 127.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 18.3x Β· peers 49.7x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably RPM International can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $208M | $221M | $244M | $306M | $318M |
| Debt incl. finance leases | $2.7B | $2.7B | $2.1B | $2.6B | $2.5B |
| Net debt / EBITDA | 2.9x | 2.7x | 1.8x | 2.2x | 1.9x |
| Debt / equity | 1.4x | 1.3x | 0.9x | 0.9x | 0.8x |
| Interest coverage | 7.9x | 6.5x | 7.7x | 9.2x | 8.8x |
| Current ratio | 1.6x | 2.1x | 2.0x | 2.2x | 1.7x |
| Quick ratio | 1.0x | 1.4x | 1.3x | 1.5x | 1.2x |
| Total assets | $6.7B | $6.8B | $6.6B | $7.8B | $8.3B |
| Total liabilities | $4.7B | $4.6B | $4.1B | $4.9B | $5.0B |
| Shareholders' equity | $2.0B | $2.1B | $2.5B | $2.9B | $3.3B |
| Net debt (β = net cash) | $2.5B | $2.5B | $1.9B | $2.3B | $2.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.5M
3 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 8 / 9 | 6 / 9 |
| Accruals ratio | β8.0% | β1.1% | β2.9% |
| Altman Z'' | 4.36 | 4.16 | 3.98 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| RPM International RPM | $12.6B | 6.7% | β | 8.6% | 13.9% | 18.3x | 6 | |
| Eastman Chemical EMN | $7.5B | β6.7% | β | 4.8% | 6.5% | 16.9x | 5 | Compare β |
| Celanese CE | $5.3B | β7.1% | β8.2% | 8.4% | β3.7% | β | 5 | Compare β |
| International Flavors & Fragrances IFF | $24.2B | β5.2% | β3.5% | 2.4% | β1.4% | 82.6x | 6 | Compare β |
| Westlake WLK | $8.3B | β8.0% | β14.1% | β4.7% | β10.0% | β | 3 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.0B | $5.3B | $5.6B | $5.5B | $6.1B | $6.7B | $7.3B | $7.3B | $7.4B | $7.9B |
| Gross profit | $2.2B | $2.0B | $2.1B | $2.1B | $2.4B | $2.4B | $2.7B | $3.0B | $3.1B | $3.3B |
| Research and development | $64.9M | $69.7M | $71.6M | $76.5M | $77.6M | $80.5M | $86.6M | $92.2M | $94.7M | $97.9M |
| Interest expense | $97.0M | $105M | $102M | $101M | $85.4M | $87.9M | $119M | $118M | $96.5M | $112M |
| Pretax income | $244M | $417M | $340M | $408M | $668M | $607M | $649M | $788M | $793M | $870M |
| Income tax | $59.7M | $77.8M | $72.2M | $103M | $165M | $114M | $170M | $198M | $102M | $208M |
| Net income | $182M | $338M | $267M | $304M | $503M | $492M | $479M | $588M | $689M | $661M |
| Diluted EPS | $1.36 | $2.50 | $2.01 | $2.34 | $3.87 | $3.79 | $3.72 | $4.56 | $5.35 | $5.17 |
| Diluted shares | 0.14B | 0.14B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| Cash flow | ||||||||||
| Cash from operations | $386M | $390M | $293M | $550M | $766M | $179M | $577M | $1.1B | $768M | $899M |
| Capital expenditure | $126M | $115M | $137M | $148M | $157M | $222M | $254M | $214M | $230M | $224M |
| Free cash flow | $260M | $276M | $156M | $402M | $609M | β$43.7M | $323M | $908M | $538M | $675M |
| Depreciation and amortization | $117M | $129M | $142M | $157M | $147M | $153M | $155M | $171M | $194M | $214M |
| Stock-based compensation | $32.5M | $25.4M | $31.2M | $19.8M | $40.9M | $40.1M | $28.7M | $25.9M | $27.0M | $32.8M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $21.9M | $17.2M | $200M | $125M | $50.0M | $52.5M | $50.0M | $55.0M | $70.0M | $77.5M |
| Dividends paid | $157M | $168M | $181M | $185M | $195M | $204M | $214M | $232M | $256M | $272M |
| Dividends and buybacks | $179M | $185M | $382M | $310M | $245M | $257M | $264M | $287M | $326M | $349M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $351M | $342M | $232M | $241M | $251M | $208M | $221M | $244M | $306M | $318M |
| Total debt | $2.1B | $2.2B | $2.5B | $2.5B | $2.4B | $2.7B | $2.7B | $2.1B | $2.6B | $2.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $2.4B | $2.5B | $2.5B | $2.4B | $2.8B | $3.2B | $3.2B | $2.9B | $3.2B | $3.5B |
| Current liabilities | $1.2B | $1.0B | $1.5B | $1.1B | $1.3B | $2.0B | $1.5B | $1.5B | $1.5B | $2.1B |
| Inventory | $788M | $835M | $842M | $810M | $938M | $1.2B | $1.1B | $957M | $1.0B | $1.1B |
| Property and equipment, net | $743M | $780M | $819M | $850M | $965M | $1.1B | $1.2B | $1.3B | $1.5B | $1.6B |
| Total assets | $5.1B | $5.3B | $5.4B | $5.6B | $6.3B | $6.7B | $6.8B | $6.6B | $7.8B | $8.3B |
| Total liabilities | $3.7B | $3.6B | $4.0B | $4.4B | $4.5B | $4.7B | $4.6B | $4.1B | $4.9B | $5.0B |
| Shareholders' equity | $1.4B | $1.6B | $1.4B | $1.3B | $1.7B | $2.0B | $2.1B | $2.5B | $2.9B | $3.3B |
| Margins | ||||||||||
| Gross margin | 43.7% | 37.9% | 37.5% | 38.0% | 39.4% | 36.3% | 37.9% | 41.1% | 41.4% | 41.4% |
| EBITDA margin | 9.2% | 12.2% | 10.5% | 12.1% | 14.8% | 12.6% | 12.7% | 14.7% | 14.7% | 15.2% |
| Net margin | 3.7% | 6.4% | 4.8% | 5.5% | 8.2% | 7.3% | 6.6% | 8.0% | 9.3% | 8.4% |
| FCF margin | 5.2% | 5.2% | 2.8% | 7.3% | 10.0% | β0.7% | 4.5% | 12.4% | 7.3% | 8.6% |
| Returns | ||||||||||
| Return on capital | 8.7% | 12.8% | 9.7% | 10.5% | 15.3% | 13.5% | 12.5% | 15.1% | 16.1% | 13.9% |
| Return on capital employed | 9.0% | 12.9% | 10.8% | 12.1% | 15.9% | 14.5% | 15.4% | 17.4% | 15.6% | 15.6% |
| Return on equity | 13.0% | 22.0% | 17.6% | 22.8% | 33.5% | 26.4% | 23.2% | 25.3% | 25.5% | 21.4% |
| Return on assets | 3.7% | 6.5% | 5.0% | 5.5% | 8.5% | 7.6% | 7.1% | 8.8% | 9.6% | 8.2% |
| Growth | ||||||||||
| Revenue growth | 3.0% | 7.3% | 4.6% | β1.0% | 10.9% | 9.9% | 8.2% | 1.1% | 0.5% | 6.7% |
| Net income growth | β48.7% | 85.8% | β21.1% | 14.2% | 65.1% | β2.2% | β2.6% | 22.9% | 17.0% | β4.0% |
| EPS growth | β48.3% | 83.8% | β19.6% | 16.4% | 65.4% | β2.1% | β1.9% | 22.6% | 17.3% | β3.4% |
| FCF growth | β27.3% | 6.1% | β43.4% | 157.5% | 51.4% | β107.2% | β | 181.5% | β40.7% | 25.4% |
| Share count change | β1.1% | 1.5% | β2.1% | β3.2% | β0.8% | 0.5% | β0.6% | β0.4% | β0.1% | β0.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.8x | 2.8x | 3.9x | 3.5x | 2.4x | 2.9x | 2.7x | 1.8x | 2.2x | 1.9x |
| Debt / equity | 1.5x | 1.3x | 1.8x | 2.0x | 1.4x | 1.4x | 1.3x | 0.9x | 0.9x | 0.8x |
| Interest coverage | 3.5x | 5.0x | 4.3x | 5.0x | 8.8x | 7.9x | 6.5x | 7.7x | 9.2x | 8.8x |
| Current ratio | 1.9x | 2.5x | 1.6x | 2.2x | 2.1x | 1.6x | 2.1x | 2.0x | 2.2x | 1.7x |
| Quick ratio | 1.3x | 1.6x | 1.1x | 1.5x | 1.4x | 1.0x | 1.4x | 1.3x | 1.5x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.5% | 2.2% | 2.5% | 2.7% | 2.6% | 3.3% | 3.5% | 2.9% | 3.1% | 2.8% |
| Stock comp / revenue | 0.7% | 0.5% | 0.6% | 0.4% | 0.7% | 0.6% | 0.4% | 0.4% | 0.4% | 0.4% |
| Payouts / FCF | 68.7% | 67.0% | 244.4% | 77.1% | 40.2% | β | 81.8% | 31.6% | 60.5% | 51.7% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 7.0 | 5.0 | 8.0 | 8.0 | 2.0 | 8.0 | 7.0 | 8.0 | 6.0 |
| Altman Z'' | 3.1 | 3.8 | 3.0 | 3.4 | 3.7 | 3.3 | 4.0 | 4.4 | 4.2 | 4.0 |
| Accruals ratio | β4.2% | β1.0% | β0.5% | β4.4% | β4.4% | 4.8% | β1.5% | β8.0% | β1.1% | β2.9% |
Source: SEC EDGAR XBRL filings (CIK 0000110621). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.